{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:15:24Z","timestamp":1778634924750,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA007027"],"award-info":[{"award-number":["T32DA007027"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS07015"],"award-info":[{"award-number":["R01NS07015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.neuropharm.2019.03.020","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T06:12:03Z","timestamp":1552543923000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats"],"prefix":"10.1016","volume":"151","author":[{"given":"Megan J.","family":"Moerke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.03.020_bib1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/0269881116689257","article-title":"Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents","volume":"31","author":"Altarifi","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/FBP.0b013e328358593c","article-title":"Role of micro-opioid receptor reserve and micro-agonist efficacy as determinants of the effects of micro-agonists on intracranial self-stimulation in rats","volume":"23","author":"Altarifi","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FBP.0b013e328364c0bd","article-title":"Abuse-related effects of micro-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure","volume":"24","author":"Altarifi","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00213-014-3719-7","article-title":"Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats","volume":"232","author":"Altarifi","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1476-5381.2012.02214.x","article-title":"Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats","volume":"168","author":"Bauer","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib6","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00213-013-3405-1","article-title":"The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats","volume":"231","author":"Bauer","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib7","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1523\/JNEUROSCI.23-32-10265.2003","article-title":"Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice","volume":"23","author":"Bohn","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","article-title":"Abuse-related and abuse-limiting effects of methcathinone and the synthetic \"bath salts\" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats","volume":"231","author":"Bonano","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3565(25)33426-9","article-title":"Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation","volume":"224","author":"Brocco","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0014-2999(76)90099-6","article-title":"Separation of inhibiting and stimulating effects of morphine on self-stimulation behaviour by intracerebral microinjections","volume":"36","author":"Broekkamp","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fpsyt.2018.00283","article-title":"Non-medical cannabis self-exposure as a dimensional predictor of opioid dependence diagnosis: a propensity score matched analysis","volume":"9","author":"Butelman","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-3565(25)20761-3","article-title":"Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor","volume":"278","author":"Emmerson","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2015.01.022","article-title":"Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice","volume":"150","author":"Grim","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41386-018-0071-3","article-title":"Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats","volume":"43","author":"Johnson","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.112.197780","article-title":"Dissociable effects of the cannabinoid receptor agonists Delta9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats","volume":"343","author":"Kwilasz","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.117.246215","article-title":"Repeated morphine produces sensitization to reward and tolerance to antiallodynia in male and female rats with chemotherapy-induced neuropathy","volume":"365","author":"Legakis","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00451687","article-title":"Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine","volume":"98","author":"Lett","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jm801272c","article-title":"Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists","volume":"52","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2010.01.024","article-title":"Chronic WIN55,212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat","volume":"209","author":"Mavrikaki","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/pha0000042","article-title":"Effects of repeated morphine on intracranial self-stimulation in male rats in the absence or presence of a noxious pain stimulus","volume":"23","author":"Miller","year":"2015","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008877-199605000-00007","article-title":"Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor","volume":"7","author":"Morgan","year":"1996","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0022-3565(24)35015-3","article-title":"Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement","volume":"290","author":"Negus","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.112.007419","article-title":"Intracranial self-stimulation to evaluate abuse potential of drugs","volume":"66","author":"Negus","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.peptides.2018.10.007","article-title":"Determinants of opioid abuse potential: insights using intracranial self-stimulation","volume":"112","author":"Negus","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib26","series-title":"Methods of Assessing the Reinforcing Properties of Abused Drugs","first-page":"391","article-title":"Tests involving pressing for intracranial stimulation as an early procedure for screening the likelihood of addiction of opioids and other drugs","author":"Reid","year":"1987"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-3565(24)37462-2","article-title":"Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus","volume":"285","author":"Selley","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib29","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1523\/JNEUROSCI.16-08-02684.1996","article-title":"Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coph.2016.11.007","article-title":"Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics","volume":"32","author":"Siuda","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2019.03.020_bib32","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.drugalcdep.2011.12.018","article-title":"Common liability to addiction and \"gateway hypothesis\": theoretical, empirical and evolutionary perspective","volume":"123","author":"Vanyukov","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in addressing the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130050534","article-title":"In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay","volume":"136","author":"Walker","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2019.03.020_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/jpet.115.228940","article-title":"Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on intracranial self-stimulation in rats","volume":"356","author":"Wiebelhaus","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nn1636","article-title":"An essential role for DeltaFosB in the nucleus accumbens in morphine action","volume":"9","author":"Zachariou","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.020_bib37","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0022-3565(24)36508-5","article-title":"Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers","volume":"280","author":"Zacny","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830426X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830426X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:00:22Z","timestamp":1778634022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081830426X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"alternative-id":["S002839081830426X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}